Skip to main navigation
WINDTREE THERAPEUTICS logo

Header Nav

  • Company
    • Company Overview
    • Management
    • Board of Directors
    • Corporate Governance
    • Contact Us
    • Diversity, Inclusion and Innovation
  • Pipeline and Technology
    • Pipeline and Therapeutic Overview
    • Istaroxime
    • SERCA2a Activators
    • Lucinactant (KL4 surfactant)
    • AEROSURF®
    • Rostafuroxin
    • Expanded Access Policy
  • Business Development
  • Investors
    • Welcome
    • Financial Information
      • IR Snapshot
      • Annual Reports
      • Analyst Coverage
    • Financial Fundamentals
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Filings
      • SEC Filings
      • Ownership
    • Corporate Governance
    • Corporate Presentation
    • Events
    • Press Releases
    • Investor Alerts
  • Contact Us
Select Page

SEC Filing Details

Header Nav

  • Welcome
  • Financial Information
    • IR Snapshot
    • Annual Reports
    • Analyst Coverage
  • Financial Fundamentals
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
  • Filings
    • SEC Filings
    • Ownership
  • Corporate Governance
  • Corporate Presentation
  • Events
  • Press Releases
  • Investor Alerts

Toolkit

  • Email Alerts
  • Print Page
  • Share
  • RSS Feeds
  • Contact IR
  • Search

Document Details

Form
8-K
Filing Date
Dec 5, 2022
Document Date
Dec 5, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Windtree Therapeutics, Inc
Issuer
WINDTREE THERAPEUTICS INC /DE/

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
YM Twitter Feed
© Copyright 2023 Windtree Therapeutics, Inc